288 related articles for article (PubMed ID: 36798145)
1. Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir "S-217622": A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species.
Eltayb WA; Abdalla M; Rabie AM
ACS Omega; 2023 Feb; 8(6):5234-5246. PubMed ID: 36798145
[TBL] [Abstract][Full Text] [Related]
2. Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study.
Rabie AM; Eltayb WA
Mol Biotechnol; 2024 Apr; 66(4):592-611. PubMed ID: 36690820
[TBL] [Abstract][Full Text] [Related]
3. A Series of Adenosine Analogs as the First Efficacious Anti-SARS-CoV-2 Drugs against the B.1.1.529.4 Lineage: A Preclinical Repurposing Research Study.
Rabie AM; Abdalla M
ChemistrySelect; 2022 Dec; 7(46):e202201912. PubMed ID: 36718467
[TBL] [Abstract][Full Text] [Related]
4. Promising Experimental Anti-SARS-CoV-2 Agent "SLL-0197800": The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus.
Rabie AM; Abdel-Dayem MA; Abdalla M
ACS Omega; 2023 Oct; 8(39):35538-35554. PubMed ID: 37810715
[TBL] [Abstract][Full Text] [Related]
5. Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential:
Rabie AM; Abdalla M
ACS Bio Med Chem Au; 2022 Dec; 2(6):565-585. PubMed ID: 37582236
[TBL] [Abstract][Full Text] [Related]
6. Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising
Rabie AM; Eltayb WA
Adv Redox Res; 2023 Jan; ():100064. PubMed ID: 36776420
[TBL] [Abstract][Full Text] [Related]
7. Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant.
Abdalla M; Rabie AM
Comput Biol Chem; 2023 Jun; 104():107768. PubMed ID: 36842392
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study.
Rabie AM; Abdalla M
Med Chem Res; 2023; 32(2):326-341. PubMed ID: 36593869
[TBL] [Abstract][Full Text] [Related]
9. Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease.
Rabie AM
ACS Omega; 2022 Jun; 7(25):21385-21396. PubMed ID: 35785294
[TBL] [Abstract][Full Text] [Related]
10. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19.
Rabie AM
Curr Res Pharmacol Drug Discov; 2021; 2():100055. PubMed ID: 34870153
[TBL] [Abstract][Full Text] [Related]
11. CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy.
Rabie AM
Mol Divers; 2021 Aug; 25(3):1839-1854. PubMed ID: 33389560
[TBL] [Abstract][Full Text] [Related]
12. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
13. 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.
Zhao J; Zhang G; Zhang Y; Yi D; Li Q; Ma L; Guo S; Li X; Guo F; Lin R; Luu G; Liu Z; Wang Y; Cen S
Antiviral Res; 2021 Dec; 196():105209. PubMed ID: 34801588
[TBL] [Abstract][Full Text] [Related]
14. Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles.
Rabie AM
Chem Biol Interact; 2021 Jul; 343():109480. PubMed ID: 33887223
[TBL] [Abstract][Full Text] [Related]
15. Potent Inhibitory Activities of the Adenosine Analogue Cordycepin on SARS-CoV-2 Replication.
Rabie AM
ACS Omega; 2022 Jan; 7(3):2960-2969. PubMed ID: 35071937
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain.
Rabie AM
J Mol Struct; 2021 Dec; 1246():131106. PubMed ID: 34305173
[TBL] [Abstract][Full Text] [Related]
17. RETRACTED ARTICLE: Discovery of (
Rabie AM
Chem Zvesti; 2021; 75(9):4669-4685. PubMed ID: 34025012
[TBL] [Abstract][Full Text] [Related]
18. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
19. Cyanorona-20: The first potent anti-SARS-CoV-2 agent.
Rabie AM
Int Immunopharmacol; 2021 Sep; 98():107831. PubMed ID: 34247016
[TBL] [Abstract][Full Text] [Related]
20. Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally.
Kawashima S; Matsui Y; Adachi T; Morikawa Y; Inoue K; Takebayashi S; Nobori H; Rokushima M; Tachibana Y; Kato T
Biochem Biophys Res Commun; 2023 Feb; 645():132-136. PubMed ID: 36689809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
